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The Kleine–Levin Syndrome is a differential diagnosis for patients with diurnal excessive
sleepiness and a suspicion of narcolepsy. It is characterized by paroxysmal attacks of diurnal
excessive sleepiness, associated with one or more symptoms of hyperphagia, hypersexu-
ality, coprolalia and copropraxia. During crisis intervals, there are no symptoms. This
pathology predominantly manifests itself in teenagers, being more frequent among males.
The course of this disease is unpredictable, with variable duration and frequency. The most
accepted physiopathology is that of a hypothalamic dysfunction, although and recently,
there has appeared a hypothesis of a post-infectious autoimmune disorder. These patients
show an elevated body mass index, which can predispose to association with comorbidities
such as the sleep obstructive apnea syndrome. Treatment involves medications with
different effects, but there is no speciﬁc and effective therapy. Our article shows a classic
case of Kleine–Levin Syndrome associated with sleep obstructive apnea syndrome, a rare
association in the literature.
& 2014 Brazilian Association of Sleep. Production and Hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The Kleine–Levin Syndrome (KLS) is a disease characterized by
recurrent periods of hyper-sleepiness, with absence of urinary
incontinence and the presence of verbal responses to intense
stimuli. Hyperphagia, hypersexuality and behavioral or cognitive
alterations (irritability, aggressiveness, mental confusion, andep. Production and Hosti
licenses/by-nc-nd/3.0/).
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lhesa, 529, Vila Clementi
(J. Castro).disorientation) are signs and symptoms found in isolation or in
conjunction among these patients. A KLS patient might sleep for
18 hours a day and the crisis usually manifests at least once a
year, ranging from 3 days to 3 weeks [1,2]. At crisis intervals,
behavior, cognition and sleep are normal.
The disorder is more frequent among teenagers of the
male gender [1–5] and has an unpredictable course withng by Elsevier B.V. This is an open access article under the CC BY-
no, CEP 04020-060, São Paulo, SP, Brasil. Tel.: þ55 11 59087191.
Table 1 – General characteristics.
Basal After 5 years
Age (years) 19 24
Height (m) 1.78 1.78
Weight (kg) 101.8 113.0
IMC (kg/m2) 32.1 35.7
Cervical circumference (cm) 43 44
Abdominal circumference (cm) 100 110
Arterial blood pressure (mmHg) 130 80 140 80
Body mass index (BMI).
S l e e p S c i e n c e 7 ( 2 0 1 4 ) 1 2 2 – 1 2 5 123remissions and recurrences which can last for years. This
disease can disappear as subtly as it appears (an average
of 8–13 years duration) [2,5].
The ﬁrst KLS episode is generally preceded by an event
associated with the beginning of the symptoms, more com-
monly an infection, alcohol ingestion, sleep deprivation,
stress, physical exhaustion, travels, brain trauma, surgeries
with local or general anesthesia, lactation, menstruation and
the use of drugs [2,3,5–7]. The precipitating factors are found
more easily at the ﬁrst episode of the disorder, being much
less frequent in subsequent episodes [2,4].
Patients may also refer intense dreams, hallucinations,
persecution nightmares and compulsions. They may also
show difﬁculty of speech and reading, disorientation and
perception alterations [2,5]. Sleep paralysis and cataplexy are
not common. Patients during a crisis are able to wake up
spontaneously to go to the bathroom and eat, but may
become aggressive and irritated if awoken or impeded of
sleeping [2]. Hypersexuality is more frequent among men and
appears to be predictive of a more prolonged disease [2,4,5].
Dis-autonomic complaints may be identiﬁed in up to 25% of
the patients (heavy sudoresis, blushing, congested or edema-
tous face, hypotension, bradycardia and nausea) [4]. After the
crisis, the patient might show insomnia, sometimes asso-
ciated with euphoria and to partial amnesia with a duration
of up to 24 h [2,4,5].2. Clinical case
FSM, 19 years old, born in the state of São Paulo, began to
show the symptoms in March, 2008, at 14 years of age, with
“excessive sleepiness periods”, referred by his parents.
The patient was born through a C section, normally and
without any problems. The patient had normal neuropsycho-
motor development, vaccination according to the Brazilian
schedule and without history of previous diseases. The
patient's mother referred that the patient ate too much,
although the food was not of a high nutritional content. His
sleep pattern involved a 30 min nap after lunch, waking up
well and sleepless. He usually went to bed between 22 and
23:00 h, taking about 30 min to sleep and waking up at 5:30 h
in the morning. He slept about 6 h during the week and
between 9 and 10 h on weekends. In addition, he showed
eventual somniloquy and high and constant snoring, without
episodes of observed apnea. There was no familiar history of
excessive sleepiness. His parents demonstrated eventualsnoring and the mother was hypertense and obese. The
diurnal excessive sleepiness (DES) attacks began around 13
years of age and had a duration of 8–17 days and were only
interrupted by familiar interference. The attacks were accom-
panied by a lethargic behavior with intense apathy as a
triggering factor. Concomitantly, there was a decrease in
verbal communication – “answered only when asked some-
thing” – demonstrating increased sudoresis as the crisis
intensiﬁed.
At physical examination, the patient was of 1.78 m height,
101.8 kg weight, with cervical and abdominal circumference
of 43 cm and 100 cm, respectively; regular 2-beat cardiac
rhythm, heart rate of 80 bpm and arterial pressure of 130/
80 mmHg. Table 1 shows the main characteristics of the
patient. Oral examination demonstrated elongated uvula,
web palate, tonsils occupying less than 50% of the oral-
pharynx and a Mallampati index of grade II.
At ﬁrst consultation, the patient was already being fol-
lowed up by a psychiatrist and was taking venlafaxine 75 mg/
day and oxycarbamezepine 300 mg/day. His performance at
school had not been decreasing and his grades followed the
pattern before the onset of the disease. The psychiatrist
described that the teenager had shown persecutory delirium
at the onset of the disorder and that the crisis were triggered
by stress. There were no complaints of hallucinations or
cataplexy. The patient referred “laziness”, “sleepiness”, and
“slow thinking” at the beginning of the crisis, isolated himself
during the crisis and only awoke to eat or go to the bathroom
and stated that he did not have recollection of what was
going on during the crisis. The family described hypersexu-
ality during the crisis. The interval between crises was of 3
and 4 months’ duration. The patient also referred that his
anxiety triggered his crisis. When awake during the crisis, the
patient stayed quiet, did not laugh or talk to the family,
demonstrating sudoresis and normal thinking process.
The ﬁrst polysonogram, in May 2009, demonstrated
increase in the percentage of slow waves, without other
alterations. The electroencephalogram demonstrated diffuse
slowing waves during crisis. The diagnosis was that of
Kleine–Levin Syndrome and we initiated a reduction of
venlafaxine to 37.5 mg/day until posterior suspension. The
dose for oxycarbamazepine was increased to 450 mg/twice
daily.
His humor progressively improved along the days of treat-
ment. He ﬁnished high school and is now working. However,
since he has been taking oxycarbamazepine 600mg/day, his
family describes that his humor only improved (“he is less
S l e e p S c i e n c e 7 ( 2 0 1 4 ) 1 2 2 – 1 2 5124irritated”) and does not demonstrate effect upon his crisis. The
young man retains his sleeping habits at periods between
crises, referring heavy sleepiness during the week and naps
during the afternoon, without sleepiness during weekends.
He denies parasomnia, sleep paralysis, hallucinations and cata-
plexy.
After 5 years of the initial diagnosis, the patient referred
snoring, agitated sleep and choking during the night, being
directed to a new polysonogram. His weight was 113 kg,
height was 1.78 m (IMC¼35.7), with abdominal circumference
of 110 cm, cervical circumference of 44 cm and arterial blood
pressure of 140/80 mmHg. He had an epworth sleepiness
scale of 16 (of a total of 24). Biochemical evaluation showed
normalcy. Brain nuclear magnetic resonance (MR) was nor-
mal (as tested on 09/04/2012). Test for the presence of HLA-
DQB1n0602 resulted negative. The test for sleep multiple
latencies during normal periods did not demonstrate DES
(the patient did not sleep during any of the registries).
The last referred crises and their duration times were:
02/2012 (15 days); 04/2012 (8 days); and 21/06/2012 (the number
of days were not reported); the last consultation was at 21/01/13
with one report of a crisis of 7 days’ duration after 09/2012.
The polysonogram of 07/04/12 showed latencies for the
beginning of sleep and normal REM sleep, good sleep efﬁ-
ciency and total sleep time of 442 min. Sleep stage N3, slightly
increased (27.3%) and the REM sleep was normal (20.4%). An
awakening index of 11.6/h was reported, along with the
absence of repeated leg movements (RLMs) and the apnea
and hypopnea index equal to 30.8/h, with basal saturation of
96.5% and minimum of 77%. The positive pressure titration
(31/05/2012) indicated an ideal pressure for apnea and hypop-
nea control of 8 cmH2O (Table 2). The patient initiated
frequent use of the continuous pressure equipment (CPAP)
in June 2012, being well adapted to the mask and with a total
decrease of the sleepiness crisis frequency until today.
Electrophysiological examinations were no longer conducted
due to the good clinical evolution.3. Discussion
The most studied physiopathology for KLS is that of a
hypothalamic dysfunction, which would justify the alterationsTable 2 – Pre- and post-CPAP polysonogram parameters.
Total sleep time (min)
Sleep efﬁciency (%)
Latency for beginning of sleep (min)
Latency for REM sleep (min)
N1 (%)
N2 (%)
N3 (%)
REM (%)
AHI (events/h)
Awakening index (events/h)
SaO2 average (%)
SaO2 minimum (%)
Oxygen arterial saturation (SaO2); Apnea and Hypopnea Index (AHI).of the sleep regulatory system, sexual behavior and appetite.
However, some published studies were not capable of identi-
fying consistent abnormalities [1,5]. Actually, there is a new
hypothesis of post-infectious autoimmune disorder, where a
viral or any other etiological agent would trigger the develop-
ment of this disease with association of histocompatibility
complexes (HLA-DR and HLA-DQB1n0201) [4,6,8]. However,
there is no deﬁnitive proof for it, since there are no studies
that found that correlation [3,5]. Even though 98% of the cases
are sporadic, there are also reports of familiar cases with
multiple cases of KLS [2]. Homozygous twins do show the
syndrome after a case of ﬂu and HLA research found the
presence of the alleles DQB1n0302/0601 and DRB1n0407/1502,
strengthening the hypothesis of a immunologic etiology and
genetically associated [8,9].
The presence of periodical respiration during the N1 and
N2 phases and central apnea in patients with KLS has been
described. However, they were not associated with CO2
retention, suggesting a possible hypo-excitability of the
respiratory center [10,11].
Patients with KLS used to demonstrate high level of body
mass index (BMI) due to elevated blood levels of leptine [5].
Epidemiological studies have shown that weight and IMC are
strong risk factors for Obstructive Sleep Apnea Syndrome (OSA),
mainly in men. In theory, the progressive increase of IMC in
these patients might lead to an increased prevalence of OSA.
The treatment of KLS involves several medications. How-
ever, there is no speciﬁc or effective therapy for the problem
[3]. Among the stimulants, amantadine may possess signiﬁ-
cant effect upon the ending of a crisis at the beginning of the
treatment, but it loses its efﬁcacy with repeated use; mod-
aﬁnil, methylphenidate and amphetamine occasionally
increase awareness, but do not improve the cognitive com-
plaints [2,5]. Antidepressants such as bupropione and ﬂuox-
etine have limited effect upon cases with depressive
behavior, but lack the prophylactic effect upon the disease
[2,5]. Neuroleptics are not efﬁcacious in treating the psychotic
symptoms, de-realization and behavioral symptoms, although
risperidone may act upon cases that are followed by delirium.
Lithium and valproate might help to prevent the recurrence of
this type of symptom [2,4,5]. Presently, the drug treatment does
not help the patients with KLS. Very few improvements with
this type of treatment have been reported [5].Basal After CPAP
442 422.5
91.8 94.9
10.3 5.8
94 103.5
7.4 4.4
45 34.4
27.3 28.3
20.4 32.9
30.8 0.9
11.6 10.8
96.5 97.1
77 92
S l e e p S c i e n c e 7 ( 2 0 1 4 ) 1 2 2 – 1 2 5 125Differential diagnoses like narcolepsy, no convulsive epi-
leptic status [1,6], familiar hemiplegic migraine, hypothalamic
tumors and psychiatric disorders must always be researched.
In patients with KLS, OSA must always be included and
treated for high prevalence in terms of weight gain in this
population [6].4. Conclusion
This article reports a very interesting case of KLS with clinical
worsening after OSA association. It demonstrates that with
OSA being diagnosed, this treatment is truly beneﬁcial to
patients with this comorbity.
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